Harbinger Health
PrivateLast Round
Series B
Extension
Apr 14, 2026
Total Funding Raised
$290M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Harbinger Health operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B Extension round in April 2026.
Harbinger Health is a biotechnology company that develops AI-enabled, blood-based multi-cancer detection tests designed to identify cancer at its earliest stages.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Harbinger Health Comparables
Compare Harbinger Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adela | 89% | |
| ClearNote Health | 86% | |
| Delfi Diagnostics | 82% |
For institutional investors. Book with your work email.
Harbinger Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 14, 2026 | ||||
| Series B | Sep 28, 2023 | ||||
| Series A | Dec 7, 2021 |
For institutional investors. Book with your work email.
Harbinger Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series B Extension, Series B |
| M&G Investments | Series B Extension, Series B |
| Partners Investment | Series B Extension, Series B |
| Flagship Pioneering | Series B Extension, Series A, Series B |
| M&G plc | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 58% MoM, reaching 4.4K.
- Apr 17, 2026
Models infer lung cancer progression from blood draw cfDNA methylation data.
For institutional investors. Book with your work email.
Harbinger Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Harbinger Health's valuation, stock price, and market status.
Is Harbinger Health a public or private company?
Harbinger Health is a private company.
What is the current stock price of Harbinger Health?
Harbinger Health is a private company, so its shares have no public market price. Caplight tracks Harbinger Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Harbinger Health worth (valuation)?
Valuation information for Harbinger Health is not publicly available.
Can I buy Harbinger Health stock?
Harbinger Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Harbinger Health's last funding round?
Harbinger Health's most recent funding round was Series B Extension on April 14, 2026.
Who are the main investors in Harbinger Health?
Key investors in Harbinger Health include Flagship Pioneering.
Will Harbinger Health IPO soon?
No public IPO plans have been announced for Harbinger Health.
How can I track Harbinger Health secondary market activity?
Caplight tracks bids, offers, and trades in Harbinger Health's shares on secondary markets.